港股異動 | 耐世特(1316.HK)大漲近10% 股價創17個月新高
格隆匯12月9日丨耐世特(1316.HK)漲幅擴大至9.59%,報9.14港元創17個月新高價,10月以來累計升幅達60%。暫成交1.37億港元,總市值229.19億港元。昨日耐世特亞太區精益學院在蘇州盛大開業,標誌着耐世特亞太區在核心工程、智能製造和精益生產體系三方面佈局的全面建立。此外,耐世特日前與大陸的合資公司開發制動轉向技術,為自動駕駛汽車提供安全宂餘。 國元國際此前表示,公司2020H2-2021年有望持續復甦。同時認為公司深耕轉向系統領域近百年,先發優勢明顯,客户基礎深厚,具備較寬的護城河。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.